Circular RNA drives resistance to anti-PD-1 immunotherapy by regulating the miR-30a-5p/SOX4 axis in non-small cell lung cancer
Cancer drug resistance in multiple myeloma
The complex relationship between multiple drug resistance and the tumor pH gradient: a review
Mechanisms of chemotherapy resistance in ovarian cancer
Targeting the complement system in pancreatic cancer drug resistance: a novel therapeutic approach
Immune checkpoint inhibitor resistance in soft tissue sarcoma
Natural bioactive compounds: a potential therapeutic strategy to sensitize bladder cancer to cisplatin treatment?
Characteristics of leukemic stem cells in acute leukemia and potential targeted therapies for their specific eradication
DNA damage and metabolic mechanisms of cancer drug resistance
Venetoclax resistance: mechanistic insights and future strategies
RIP140 regulates <i>POLK</i> gene expression and the response to alkylating drugs in colon cancer cells
Ovarian cancer recurrence: is the definition of platinum sensitivity modified by PARPi, bevacizumab or other intervening treatments? : a clinical perspective
Ovarian cancer recurrence: is the definition of platinum resistance modified by PARPi and other intervening treatments? The evolving landscape in the management of platinum-resistant ovarian cancer
Fusobacterium nucleatum: a new player in regulation of cancer development and therapeutic response
Ovarian cancer recurrence: “is the definition of platinum resistance modified by PARP inhibitors and other intervening treatments?”
Role of prostate cancer stem-like cells in the development of antiandrogen resistance
An overview of resistance to Human epidermal growth factor receptor 2 (Her2) targeted therapies in breast cancer
Molecular vulnerabilities and therapeutic resistance in hormone receptor positive and HER2 dependent breast cancer tumours
Transcriptional coactivator MED1 in the interface of anti-estrogen and anti-HER2 therapeutic resistance
Multicellular biomarkers of drug resistance as promising targets for glioma precision medicine and predictors of patient survival